Perioperative Dexamethasone as an adjunct pain reliever for women undergoing elective Caesarean section in UITH: a double-blind randomised placebo-controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202602674591846

Enrollment

190

Registered

2026-02-02

Start date

2026-03-02

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

intravenous dexamethasone

Placebo

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: i. Women who are 18 years and above who are scheduled for elective CS under spinal anaesthesia ii. American Society of Anaesthesiologists’ physical status I or II

Exclusion criteria

Exclusion criteria: i. Known allergy to steroids ii. Pre-existing chronic pain disorder (like patients with haemoglobinopathy, arthritis) iii. Chronic use of steroids (more than 2 weeks within the preceding 3 months) iv. Peptic ulcer disease v. Coagulopathy vi. Psychiatric illness vii. Diabetes mellitus viii. History of glaucoma ix. Use of corticosteroids or opioids within 24 hours before surgery

Design outcomes

Primary

Measure	Time frame
Postoperative adjunctive analgesic effect, assessed using pain score (with VRS 0-4, where 0= no pain and 4= excruciating pain).	—

Secondary

Measure	Time frame
i. Total dose of opioid consumption in 24 hours ii. Time to first request for rescue analgesia iii. Patients with postoperative nausea and vomiting iv. Patient’s satisfaction with postoperative pain management	—

Countries

Nigeria

Contacts

Public ContactMUNIRDEEN ADEREMI IJAIYA

Supervisor

munirijaiya@yahoo.com+2348033801565

Outcome results